Understanding how certain brain cells control cataplexy in narcolepsy
Neural Mechanisms Underlying Cataplexy Control by MCH Neurons
This study is looking at how certain brain cells called MCH neurons affect cataplexy, which is when people suddenly lose muscle control, and it's aimed at helping those with narcolepsy by finding new ways to manage this condition.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Beth Israel Deaconess Medical Center NIH-funded |
| Lab location | 1 site (Boston, United States) |
| Project ID | NIH-11081001 on NIH RePORTER |
What this research studies
This research investigates the role of melanin-concentrating hormone (MCH) neurons in the control of cataplexy, a sudden loss of muscle tone associated with narcolepsy. Using a mouse model, the study will observe the activity of MCH neurons during episodes of cataplexy and in response to positive emotional stimuli. The researchers will employ advanced techniques to selectively activate or silence these neurons to determine their causal role in cataplexy. This work aims to clarify the neural circuitry involved and could lead to new therapeutic strategies for managing this debilitating condition.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with narcolepsy who experience cataplexy.
Not a fit: Patients without narcolepsy or those who do not experience cataplexy are unlikely to benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new treatments that better control cataplexy in patients with narcolepsy.
How similar studies have performed: Previous research has shown promising results in understanding the role of orexin neurons in narcolepsy, suggesting that exploring MCH neurons may also yield significant insights.
Where this research is happening
Boston, United States
- Beth Israel Deaconess Medical Center — Boston, United States (Active)
Researchers
- Principal investigator: Ramalingam, Vetrivelan — Beth Israel Deaconess Medical Center
- Study coordinator: Ramalingam, Vetrivelan
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.